Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Diapositiva 1
Transcript
Castrate-Sensitive Metastatic PC OS by extent of metastatic disease at start of ADT Presented By Christopher Sweeney at 2014 ASCO Annual Meeting Metastatic Hormone-Sensitive Prostate Cancer: Standards in 2014 1. Continuous androgen deprivation therapy (ADT) is the standard based on optimal survival outcomes 2. Patients with new high-volume M1 prostate cancer should be offered combination ADT + Docetaxel 3. Patients should be offered access to clinical trials
